Celecoxib pathways

Five-Year Analysis of the Prevention of Colorectal Sporadic Adenomatous Polyps Trial

(2011) Nadir Arber et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prostaglandins and Inflammation

(2011) Emanuela Ricciotti et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga

(2010) Tilo Grosser et al.   Annual Review of Medicine

PharmGKB summary

(2010) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial

(2009) M. M. Bertagnolli et al.   Cancer Prevention Research

Cytochrome P450 2C9 Variants Influence Response to Celecoxib for Prevention of Colorectal Adenoma

(2009) Andrew T. Chan et al.   GASTROENTEROLOGY

Nonsteroidal Anti-Inflammatory Drugs and Lower Gastrointestinal Complications

(2009) Angel Lanas et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles

(2009) L. I. Brueggemann et al.   MOLECULAR PHARMACOLOGY

15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors

(2009) M. Yan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

(2009) R. E. Harris   INFLAMMOPHARMACOLOGY

Cyclooxygenase-2 Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Cardiovascular Risk

(2008) Orly Vardeny et al.   CARDIOLOGY CLINICS

Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials

(2008) Scott D. Solomon et al.   CIRCULATION

Cancer-Associated Carbonic Anhydrases and Their Inhibition

(2008) J. Pastorek et al.   CURRENT PHARMACEUTICAL DESIGN

Cyclooxygenases: structural and functional insights

(2008) Carol A. Rouzer et al.   JOURNAL OF LIPID RESEARCH